This site has limited support for your browser. We recommend switching to Edge, Chrome, Safari, or Firefox.

Celebrate Mothers’s Day10% OFF any purchase until May 10th. Use code MOM10

Use coupon code WELCOME10 for 10% off your first order.

Cart 0

Congratulations! Your order qualifies for free shipping You are $200 away from free shipping.
Sorry, looks like we don't have enough of this product.

Products
Pair with
Is this a gift?
Subtotal Free
Shipping, taxes, and discount codes are calculated at checkout

Your Cart is Empty

Model-SENSITIVE_0ee4523e-c783-47ce-a9a7-5e03a7aadd6e.png

Combating Chronic Inflammation ("Inflammaging")

A Primary Driver of Age-Related Decline

Aging is intrinsically linked to a state of chronic, low-grade systemic inflammation, a phenomenon often termed "inflammaging".[1] This persistent inflammatory state profoundly disrupts cellular balance, damages tissues, and contributes significantly to the development and progression of numerous age-related diseases. In the context of skin aging, chronic inflammation directly impacts epidermal balance, leading to common features such as skin thinning and a weakened barrier.[6] Pro-inflammatory cytokines, notably IL-1β and TNF-α, stimulate the production of matrix metalloproteinases (MMPs), enzymes that actively break down the extracellular matrix, particularly collagen. This degradation of the extracellular matrix results in reduced skin elasticity and the formation of wrinkles.6 The clear establishment of chronic inflammation as a direct cause of visible signs of aging like wrinkles and skin thinning underscores its critical role and makes its modulation highly relevant for anti-aging interventions.

MSC-Exosomes demonstrate powerful anti-inflammatory and immunomodulatory properties, making them highly effective in mitigating inflammaging.[2] They achieve this by suppressing the activation and function of various immune cells and promoting the polarization of pro-inflammatory (M1) macrophages to an anti-inflammatory (M2) phenotype, thereby reducing inflammation and protecting tissues from age-related damage.[1] Specifically, MSC-Exos downregulate key pro-inflammatory cytokines such as IL-1β, TNF-α, IL-4, and IL-13, and inhibit inflammatory pathways like NF-κB and STAT3.[6] Furthermore, they can inhibit Toll-like receptor 4 (TLR4) activity through the transfer of exosomal miR-182, contributing to their sophisticated immunomodulatory effects.[3] This targeted action helps restore a balanced immune environment, moving beyond a general anti-inflammatory effect to a precise, multi-pronged modulation of the immune response.

To illustrate the precision and breadth of MSC exosome action against inflammation, the following table summarizes their targeted mechanisms:

Mechanism of Action Specific Effects Key Molecules/Pathways Involved
Immune Cell Modulation Suppress activation & function of various immune cells; Promote M1 to M2 macrophage polarization; Inhibit dendritic cell activation Macrophages (M1/M2), Dendritic Cells, Various Immune Cells [1]
Cytokine Downregulation Reduce levels of pro-inflammatory cytokines IL-1β, TNF-α, IL-4, IL-13 [6]
Inflammatory Pathway Inhibition Block key signaling cascades that drive inflammation NF-κB pathway, STAT3 pathway, Toll-like receptor 4 (TLR4) activity (via exosomal miR-182) [3]

OUR BEST SELLER

REGENERA EXOPURE

Works cited

1. Exosome treatment for anti-ageing - Bioscience Institute, accessed July 20, 2025, https://bioinst.com/en/exosome-treatment-for-anti-ageing/

2. Extracellular vesicles derived from mesenchymal stem cells: the wine in Hebe's hands to treat skin aging, accessed July 20, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10955876/

3. Mechanism of mesenchymal stem cells and exosomes in ... - Frontiers, accessed July 20, 2025, https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1181308/full

6. Exosomes derived from mesenchymal stem cells: A novel agent for skin aging treatment | Biomedical Research and Therapy, accessed July 20, 2025, https://bmrat.org/index.php/BMRAT/article/view/946